Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices 72417 

information: 1 (866) 659–0537, Participant 

Pass Code 9933701. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that have 

been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction, which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort. 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to CDC. 

NIOSH implements this responsibility for 

CDC. The charter was issued on August 3, 

2001, renewed at appropriate intervals, and 

will expire on August 3, 2013. 

Purpose: The Advisory Board is charged 

with (a) Providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. The Subcommittee for Dose 

Reconstruction Reviews was established to 

aid the Advisory Board in carrying out its 

duty to advise the Secretary, HHS, on dose 

reconstruction. 

Matters to be Discussed: The agenda for the 

Subcommittee meeting includes: discussion 

of dose reconstruction cases under review 

(sets 7–10); DCAS dose reconstruction 

quality management and assurance activities; 

and dose reconstruction issues from NIOSH 

10-year review. 

The agenda is subject to change as 

priorities dictate. 

In the event an individual cannot attend, 

written comments may be submitted. Any 

written comments received will be provided 

at the meeting and should be submitted to 

the contact person below well in advance of 

the meeting. 

Contact Person for More Information: 

Theodore Katz, Executive Secretary, NIOSH, 

CDC, 1600 Clifton Road, Mailstop E–20, 

Atlanta, Georgia 30333, Telephone: (513) 

533–6800, Toll Free: 1 (800) CDC–INFO, 

Email: ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: November 17, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–30233 Filed 11–22–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Health and Nutrition 

Examination Survey (NHANES) DNA 

Samples 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (DHHS). 

ACTION: Notice. 

SUMMARY: The National Health and 

Nutrition Examination Survey 

(NHANES) will not be receiving DNA 

proposals in 2012. NHANES is changing 

its plan for making DNA available for 

genetic research and its proposal 

guidelines. NHANES anticipates that 

the DNA Bank will be open for 

proposals approximately January 2013. 

DATES: Effective date is date of 

publication in the Federal Register. 

ADDRESSES: Geraldine McQuillan, PhD, 

Division of Health and Nutrition 

Examination Surveys, National Center 

for Health Statistics, Centers for Disease 

Control and Prevention, 3311 Toledo 

Road, Room 4204, Hyattsville, MD 

20782, Phone: (301) 458–4371, Fax: 

(301) 458–4028, E–Mail: 

NHANESgenetics@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Geraldine McQuillan, Division of Health 

and Nutrition Examination Surveys, 

National Center for Health Statistics, 

Centers for Disease Control and 

Prevention, 3311 Toledo Road, Room 

4204, Hyattsville, MD 20782, 

Phone: (301) 458–4371, 

Fax: (301) 458–4028, 

E-Mail: NHANESgenetics@cdc.gov. 

Juliana K. Cyril, 

Deputy Director, Office of Science Quality, 

Office of the Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2011–30204 Filed 11–22–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2011–0011] 

Public Health Service Guideline for 

Reducing Transmission of Human 

Immunodeficiency Virus (HIV), 

Hepatitis B Virus (HBV), and Hepatitis 

C Virus (HCV) Through Solid Organ 

Transplantation 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (DHHS). 

ACTION: Extension of the public 

comment period. 

SUMMARY: On September 21, 2011, the 

Centers for Disease Control and 

Prevention (CDC), located within the 

Department of Health and Human 

Services (HHS), published a notice in 

the Federal Register requesting public 

comment on the draft ‘‘Public Health 

Service (PHS) Guideline for Reducing 

Transmission of Human 

Immunodeficiency Virus (HIV), 

Hepatitis B Virus (HBV), and Hepatitis 

C Virus (HCV) through Solid Organ 

Transplantation’’ (76 FR 58517). Written 

and electronic comments were to be 

received on or before November 21, 

2011. However, HHS/CDC has received 

requests for a 30 day extension of the 

comment period. In consideration of 

those requests, HHS/CDC is extending 

the comment period by 30 days to 

December 23, 2011. 

CDC also published a supporting 

document for reference, the Evidence 

Report. The Evidence Report includes 

primary evidence, studies, and data 

tables that were used by the Guideline 

authors in developing the 

recommendations in the Guideline. 

The draft Guideline is for use by organ 

procurement organizations (OPOs); 

transplant centers, including 

physicians, nurses, administrators, and 

clinical coordinators; laboratory 

personnel responsible for testing and 

storing donor and recipient specimens; 

and persons responsible for developing, 

implementing, and evaluating infection 

prevention and control programs for 

OPOs and transplant centers. This 

Guideline provides evidence-based 

recommendations for reducing 

unexpected transmission of HIV, HBV 

and HCV from deceased and living 

organ donors. 

DATES: Written comments must be 

received on or before December 23, 

2011. 

ADDRESSES: Written comments may be 

submitted electronically or by mail. To 


sroberts on DSK5SPTVN1PROD with NOTICES
72418 Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices 

download an electronic version of the 

Guideline, go to http:// 

www.regulations.gov, Docket CDC– 

2011–0011. You may submit written 

comments electronically at this Web 

site. Please follow directions at http:// 

www.regulations.gov to submit 

comments. 

You may also submit written 

comments to the following address: 

Office of Blood, Organ and Other Tissue 

Safety, Division of Healthcare 

Promotion, National Center for 

Emerging and Zoonotic Infectious 

Diseases, Centers for Disease Control 

and Prevention, (CDC), Attn: Public 

Health Service Guideline for Reducing 

Transmission of Human 

Immunodeficiency Virus (HIV), 

Hepatitis B Virus (HBV) and Hepatitis C 

Virus (HCV) through Solid Organ 

Transplantation, Docket No. CDC– 

2011–0011, 1600 Clifton Rd, NE., 

Mailstop A–07, Atlanta, Georgia, 30333. 

All written materials identified will be 

available for public inspection Monday 

through Friday, except for legal 

holidays, from 9 a.m. until 5 p.m., 

Eastern Standard Time, at 1600 Clifton 

Road, NE., Atlanta, Georgia 30333. 

Please call ahead to (404) 639–4000 and 

ask for a representative from the Office 

of Blood, Organ and Other Tissue Safety 

to schedule your visit. All relevant 

comments received will be posted 

publicly at this Web site without 

change, including any personal or 

proprietary information. 

FOR FURTHER INFORMATION CONTACT: 

Debbie Seem, Division of Healthcare 

Quality Promotion, National Center for 

Emerging and Zoonotic Diseases, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., 

Mailstop A–07, Atlanta, Georgia, 30329– 

4018; Telephone: (404) 639–4000. 

SUPPLEMENTARY INFORMATION: Since 

2008, HHS/CDC has collaborated with 

state and federal agencies, national 

partners, academicians, public and 

private health professionals, the 

transplant field, public health 

organizations, and other partners to 

revise and expand the 1994 Guidelines 

for Preventing Transmission of Human 

Immunodeficiency Virus (HIV) through 

Transplantation of Human Tissue and 

Organs. The 2011 draft Guideline 

updates the previous recommendations 

about HIV and also includes 

recommendations to reduce disease 

transmission of HBV and HCV, and 

addresses issues such as donor risk 

assessment, donor screening, HBV- and 

HCV-infected donors and 

transplantation, recipient informed 

consent, recipient screening, donor and 

recipient specimen collection and 

storage, and tracking and reporting of 

HIV, HBV, and HCV. 

As with the 1994 Guideline, the 

recommendations address adult and 

pediatric donors who are living or 

deceased, as well as transplant 

candidates and recipients. In addition to 

summarizing current scientific 

knowledge about solid organ transplant 

safety, the draft 2011 Guideline also 

identifies important gaps in the 

literature where further research is 

needed. 

HHS/CDC worked with the University 

of Pennsylvania’s Health System Center 

for Evidence-based Practice (CEP) and 

sought input in each phase of the 

Guideline’s development from subject 

matter experts in HIV and hepatitis 

through formation of a Guideline Expert 

Panel to develop the new Guideline. 

HHS/CDC also formed a Guideline 

Review Committee to provide feedback 

on the draft Guideline 

recommendations. Members of the 

Review Committee included 

representation from public health, 

regulatory, transplant infectious disease 

and other stakeholders. This new Draft 

Guideline will not be a federal rule or 

regulation. 

Juliana K. Cyril, 

Deputy Director, Office of Science Quality, 

Office of the Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2011–30205 Filed 11–22–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Statement of Organization, Functions, 

and Delegations of Authority; 

Administration on Developmental 

Disabilities 

AGENCY: Administration for Children 

and Families, HHS. 

ACTION: Notice. 

SUMMARY: Statement of Organization, 

Functions, and Delegations of 

Authority. The Administration for 

Children and Families (ACF) has 

reorganized the Office of the Assistant 

Secretary (OAS) and the Administration 

on Developmental Disabilities (ADD). 

This reorganization realigns the 

President’s Committee for People with 

Intellectual Disabilities Staff within the 

OAS and moves the function to ADD as 

a result of the Charter Amendment for 

PCPID governed by Public Law 92–463 

signed by the Secretary, HHS, on May 

9, 2011. 

FOR FURTHER INFORMATION CONTACT: 

Sharon Lewis, Commissioner, 

Administration on Developmental 

Disabilities, 200 Independence Avenue 

SW., Washington, DC 20201, (202) 690– 

6590. 

This notice amends Part K of the 

Statement of Organization, Functions 

and Delegations of Authority of the 

Department of Health and Human 

Services (HHS), Administration for 

Children and Families (ACF) as follows: 

Chapter KA, Office of the Assistant 

Secretary (OAS) last amended, 75 FR 

60471–60473, September 30, 2010, and 

Chapter KC, Administration on 

Developmental Disabilities (ADD) last 

amended 75 FR 63186–63187, October 

14, 2010. 

I. Under Chapter, KA, Amend the Office 

of the Assistant Secretary as Follows 

A. Delete KA.10 Organization in its 

entirety and replace with the following: 

KA.10 Organization. The Office of the 

Assistant Secretary for Children and 

Families is headed by the Assistant 

Secretary for Children and Families who 

reports directly to the Secretary and 

consists of: 

Office of the Assistant Secretary for 

Children and Families (KA) 

Executive Secretariat Office (KAF) 

Office of Human Services Emergency 

Preparedness and Response (KAG) 

Office of the Deputy Assistant Secretary 

and Inter-Departmental Liaison for 

Early Childhood Development (KAH) 

B. Delete KA.20 Functions B in Its 

entirety. 

II. Under Chapter, KC, Administration 

on Developmental Disabilities, Delete in 

Its Entirety and Replace With the 

Following 

KC.00 Mission. The Administration 

on Developmental Disabilities (ADD) 

advises the Secretary, through the 

Assistant Secretary for Children and 

Families, on matters relating to 

individuals with developmental 

disabilities and their families. ADD 

serves as the focal point in the 

Department to support and encourage 

the provision of quality services to 

individuals with developmental 

disabilities and their families. ADD 

assists states, through the design and 

implementation of a comprehensive and 

continuing state plan, in increasing the 

independence, productivity and 

community inclusion of individuals 

with developmental disabilities. These 

state plans make optimal use of existing 

Federal and state resources for the 

provision of services and supports to 

these individuals and their families to 

achieve these outcomes. ADD works 


sroberts on DSK5SPTVN1PROD with NOTICES